Chemical Synthesis and Optimization Facility for Advancing Non-Hormonal Contraceptive and Reproductive Health Product Development
This grant opportunity from NICHD provides support for preclinical studies to help develop new contraceptive and reproductive health therapies. The aim is to advance promising candidates to the stage where they can be tested under regulatory approvals like Investigational Device Exemption (IDE) or Investigational New Drug (IND).
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
National Institutes of Health
-
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Reagents for WRIAR office of US Embassy Tbilisi
-
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
National Institutes of Health
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers